January  •  February  •  March  •  April  •  May  •  June
July  •  August  •  September  •  October  •  November  •  December

Radioimmunotherapy: a promising treatment strategy for follicular lymphoma

Overview of hypersensitivity to cancer therapies

Cetuximab combined with chemotherapy in non-small cell lung cancer

Management of hand-foot skin reaction caused by multikinase inhibitors

Vorinostat in combination therapy for cutaneous T-cell lymphoma

Practical biostatistics: Measures of risk

Year-end cliffhanger: CMS fee cut

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Pazopanib in advanced renal cell carcinoma

ITP in patients infected with hepatitis C virus

Ampullary cancer: review and clinical update

Intraperitoneal chemotherapy for ovarian cancer

Hereditary breast and ovarian cancer testing

Acute phase adverse events following denosumab or IV bisphosphonates

Angioimmunoblastic T-cell lymphoma presenting as extensive psoriasis

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Recent developments in the treatment of NSCLC

JAK2 mutation in myeloproliferative neoplasms

First-line treatment of metastatic breast cancer

Hereditary melanoma and genetic testing

Current management of patients with cancer of unknown primary site

Preoperative evaluation and treatment of rectal cancer

Providing palliative care and transitioning patients to hospice

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Ofatumumab for fludarabine- and alemtuzumab-refractory CLL

Decreasing the frequency of medical oncology admissions

First-line treatment of patients with chronic-phase chronic myelogenous leukemia

ITP in patients with CLL: practicing with Patrick F. Fogarty, MD

Cancer-mimicking lesion in a cancer survivor

Paraneoplastic polymyositis associated with mesothelioma

Current management of patients with cancer of unknown primary site

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Oncotype DX assay for predicting recurrence of stage II colon cancer

Triple-negative breast cancer: a clinical update

Update on paraneoplastic neurologic disorders

I-SPY 2: a new path for clinical trials: a conversation with Laura Esserman, MD, MBA

A plea for new coding

Emperipolesis in giant cell carcinoma of the lung

Many groups, many factors: analysis of variance

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

OVA1 test for preoperative assessment of ovarian cancer

Rational combinations in metastatic breast cancer: bevacizumab with chemotherapy

Integrating data for the next innovation: a conversation with Laura Esserman, MD, MBA

Low rate of neutropenia and related events in patients with breast cancer receiving pegfilgrastim

Bilateral primary endodermal sinus tumor of the lung in a woman

Body counts and biostatistics: the chi-square test

Cancer costs: searching for savings

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Evaluation of reported bone pain in cancer patients receiving chemotherapy in pegfilgrastim clinical trials

The oncology practice and specialty pharmacy providers

Direct-to-consumer genetic testing and advertising: past, present, and future

Paraneoplastic myelitis related to diffuse large B-cell lymphoma and Hodgkin’s lymphoma

Treatment of triple-negative breast cancer

Practical biostatistics: relations between continuous variables

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Sipuleucel-T immunotherapy for advanced prostate cancer

Incidence and risk factors for chemotherapy-induced nausea or vomiting

Choosing prostate cancer therapy with multimedia software

Synchronous presentation of small cell and early-stage non-small cell lung cancers

Practical biostatistics: binary dependent variables—logistic regression

Highlights of the 2010 American Society of Clinical Oncology annual meeting

Oncologist shortage: is it an organizational problem?

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Ipilimumab improves survival in previously treated metastatic melanoma

Mycosis fungoides and Sézary syndrome: the burden of pruritus

Living with metastatic breast cancer: a global patient survey

Maintenance rituximab after chemotherapy in patients with low-grade lymphoma

Cancer disparities research in community hospitals

Polysorbate 80 hypersensitivity reactions

Practical biostatistics: missing data

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Activity of crizotinib in patients with non-small cell lung cancer

Implementing chemoradiation treatment for patients with cervical cancer

Successful outpatient desensitization of cancer patients with hypersensitivity reactions

Assessment of safety regarding rapid rituximab infusion

Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients

Multiple organ dysfunction syndrome secondary to micrometastatic adenocarcinoma

Practical biostatistics: survival analysis

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Dasatinib and nilotinib in first-line treatment of chronic myeloid leukemia

Axillary node dissection fails to benefit women with clinically node-negative breast cancer

Integrating antiangiogenic therapy for advanced urothelial carcinoma

Autoimmune hemolytic anemia and Hodgkin’s lymphoma

Transbronchial fine-needle aspiration cytology

Cardiac metastasis from cancer of the cervix: significant palliation with radiation therapy

Using ESAs: getting it right

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Cabazitaxel and prednisone for metastatic, castration-resistant prostate cancer

Trastuzumab-DM1 in extensively pretreated patients with HER2-positive metastatic
breast cancer

Implications of postmastectomy radiation therapy on breast reconstruction

Bevacizumab-associated bowel perforation after stent placement

Oncology patient-centered medical home and accountable cancer care

Practical biostatistics: the criteria for establishing causality

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT